Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record was updated to Terminated and now includes a new Strategic considerations section; the Petah Tikva location was broadened to include the Central District, and enrollment dates moved from estimated to actual, with a new revision timestamp.
    Difference
    0.7%
    Check dated 2026-06-05T08:29:45.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous revision tag. This reflects a system-level update to the page without altering the study information.
    Difference
    0.0%
    Check dated 2026-05-15T05:43:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333, clarifying the exact city for this enrollment site. This change improves precision in the study's location listing for Taiwan.
    Difference
    0.0%
    Check dated 2026-05-08T09:28:57.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page’s displayed revision/version footer was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:18:03.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:06.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    New study sites were added (Columbus, OH; Rabin Medical Center in Israel; Hospital Universitario Vall de Hebron in Spain) and some existing site identifiers were updated.
    Difference
    0.6%
    Check dated 2026-03-26T11:41:14.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.